Genomic Characteristics and Clonal Evolution of EGFR-mutated Lung Adenocarcinoma-Transformed Squamous Carcinoma after EGFR-TKIs Treatment

被引：0
|
作者：
Kang, J. [1 ]
Yang, X. -N. [1 ]
Yan, L. -X. [2 ]
Yan, L. [3 ]
Yang, J. -J. [1 ]
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[2] Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
[3] Shanghai Tongshu Biotech Co Ltd, Shang Hai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
epidermal growth factor receptor; lung adenocarcinoma to; squamous cell carcinoma tra; drug resistance;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-10
引用
收藏
页码：S335 / S335
页数：1
相关论文
共 50 条
  • [1] Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer
    Ito, Takashi
    Nagashima, Hiromi
    Akiyama, Masachika
    Utsumi, Yu
    Sato, Hideomi
    Chiba, Shinji
    Sugai, Mayu
    Ube, Kenji
    Mori, Yoshiaki
    Watanabe, Kana
    Fukuhara, Tatsuro
    Maemondo, Makoto
    THORACIC CANCER, 2022, 13 (03) : 386 - 393
  • [2] Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma
    Park, Sehhoon
    Shim, Joon Ho
    Lee, Boram
    Cho, Inju
    Park, Woong-Yang
    Kim, Youjin
    Lee, Se-Hoon
    Choi, Yoon La
    Han, Joungho
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    LUNG CANCER, 2019, 134 : 7 - 15
  • [3] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma
    Zheng, X.
    Huang, C.
    Lin, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma.
    Jiang, Kan
    Lin, Gen
    Zheng, Xinlong
    Long, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated with EGFR-TKIs
    Kim, I. A.
    Kim, H. J.
    Lee, J. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2138 - S2138
  • [6] Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma
    Zhu, Hui
    Ma, Xiaoyan
    Yu, Jinming
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1484 - S1484
  • [7] Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
    Ma, Xiaoyan
    Zhu, Hui
    Guo, Hongbo
    Han, Anqin
    Wang, Haiyong
    Jing, Wang
    Zhang, Yan
    Kong, Li
    Yu, Jinming
    ONCOTARGET, 2016, 7 (49) : 81906 - 81917
  • [8] Randomized Double-blind Placebo-controlled trial of Nicotinamide and EGFR-TKIs for EGFR-mutated Lung Adenocarcinoma
    Kim, Y. -C.
    Oh, I. -J.
    Park, C. -K.
    Oh, H. -J.
    Park, I. Y.
    Bae, S. -C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S442 - S443
  • [9] Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
    In Ae Kim
    Jong Sik Lee
    Hee Joung Kim
    Wan Seop Kim
    Kye Young Lee
    BMC Cancer, 18
  • [10] Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
    Kim, In Ae
    Lee, Jong Sik
    Kim, Hee Joung
    Kim, Wan Seop
    Lee, Kye Young
    BMC CANCER, 2018, 18
12345